Peru suspends trial of Chinese coronavirus vaccine as a precaution
- FTT Creations
- Dec 12, 2020
- 1 min read
Peru suspended in the last hours the clinical trial of a potential Chinese vaccine for the Covid-19 as a precaution against the detection of neurological problems in a study volunteer. The National Institute of Health (INS) decided to temporarily stop the trial, after it was reported that one of the volunteers had decreased strength in the movements of his legs, according to local media.
Germán Málaga principal investigator of the clinical trials of the Sinopharm vaccine said, a few days ago we duly reported to the regulatory entities that one of our participants had some neurological symptoms that could correspond to a complication called Guillain-Barré.
Guillain-Barré Syndrome is a rare, non-contagious disorder that affects the nerves that control movement of the arms and legs.
Recent Posts
See AllA controversial move by Germany’s center-right Union bloc (CDU/CSU) to pass stricter migration policies with support from the far-right Alte
As recovery efforts continue following Wednesday’s fatal mid-air collision over the Potomac River, international condolences and investigati
President Donald Trump intensified his criticism of federal diversity initiatives Thursday, linking them to a fatal mid-air collision over t
Comments